Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sulfonylamidine substituted compounds and their use as beta-lactamase inhibitors

Sulfonylamidine substituted compounds and their use as beta-lactamase inhibitors

US Patent 12410166 · Granted Sep 9, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, 2025
Compound for inhibiting PGE2/EP4 signaling transduction inhibiting, preparation 2025
N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, 2024
Use of Cistanche deserticola polysaccharides in promoting proliferation and diff2023
N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, 2023
Crystalline form of alkynyl pyridine prolyl hydroxylase inhibitor and method for2021
Optimized in vivo delivery system with endosomolytic agents for nucleic acid con2020
Optimized in vivo delivery system with endosomolytic agents for nucleic acid con2019
Amidine substituted β-lactam compounds, their preparation and use as antibacteri2017
Substituted 2-aminopyridine protein kinase inhibitor2017
Optimized in vivo delivery system with endosomolytic agents for nucleic acid con2017
Methods and compositions for modulating an immune response with immunogenic olig2017